Back
Ultragenyx Pharmaceutical Stock Price Chart
Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
RARE
Ultragenyx Pharmaceutical
Last Price:
$34.90
Seasonality Move:
10.92%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.36 | Buy |
| 20-day SMA: | 36.08 | Sell |
| 50-day SMA: | 39.82 | Sell |
| 200-day SMA: | 46.67 | Sell |
| 8-day EMA: | 34.09 | Buy |
| 20-day EMA: | 35.7 | Sell |
| 50-day EMA: | 38.74 | Sell |
| 200-day EMA: | 44.04 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.88 | Sell |
| Relative Strength Index (14 RSI): | 44.33 | Sell |
| Chaikin Money Flow: | 868654 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.95 - 39.53) | Sell |
| Bollinger Bands (100): | (38.16 - 46.28) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 34.92 while RARE 8-day simple moving average is 33.36, which is a Buy signal.
-
The stock price of RARE is 34.92 while Ultragenyx Pharmaceutical 20-day SMA is 36.08, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 39.82 while RARE share price is 34.92, making it a Sell technically.
-
RARE stock price is 34.92 and Ultragenyx Pharmaceutical 200-day simple moving average is 46.67, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
8
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $34.92. The Score for RARE is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.2B
Price in USD:
34.92
Share Volume:
1.2M
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
29.59
Sell
8
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 34.92 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 34.92 while RARE 8-day exponential moving average is 34.09, which is a Buy signal.
-
The stock price of RARE is 34.92 while Ultragenyx Pharmaceutical 20-day EMA is 35.70, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 38.74 while RARE share price is 34.92, making it a Sell technically.
-
RARE stock price is 34.92 and Ultragenyx Pharmaceutical 200-day simple moving average is 44.04, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.81 per share, and an increase next year of $1.90 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is -1.88, suggesting Ultragenyx Pharmaceutical is a Sell
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 44.33, which suggest Ultragenyx Pharmaceutical is oversold
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (33.95 - 39.53), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (38.16 - 46.28), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.